CAS: 51059-44-0; (2S,3S,4S,5R,6S)-3,4,5-Trihydroxy-6-((5-Hydroxy-8-Methoxy-4-Oxo-2-Phenyl-4H-Chromen-7-yl)Oxy)Tetrahydro-2H-Pyran-2-Carboxylic Acid

该化合物是来自Scutellaria baicenses植物的浮质胶质,通称为中国头骨,其特征为结构结构,由富兰松骨骨组成,带有葡萄糖味,有助于其溶解性和生物活动.Wogonoside展示了一系列药理特性,包括抗炎,抗氧化剂和抗癌症效应,使其成为医学化学和药理学的受关注对象.其行动机制往往涉及各种信号路径的调节和特定酶的抑制.此外,对浮质表面进行了研究,以了解其潜在的...

结构式图片

欧盟法规

C&L通报

上下游产品

CAS号632-85-9 汉黄芩素 | CAS号2616-64-0 UDP葡萄糖醛酸 | CAS号632-85-9 汉黄芩素

合成工艺路线路线简述

  • 合成目标产物 Beta-D-Glucopyranosiduronic Acid 主要起始原料 Wogonin And (2S,3S,4R,5R,6R)-6-[[[(2S,3S,4R,5R)-5-(2,4-Dioxopyrimidin-1-yl)-3,4-Dihydroxy-Oxolan-2-Yl]Methoxy-Hydroxy-Phosphoryl]Oxy-Hydroxy-Phosphoryl]Oxy-3,4,5-Trihydroxy-Oxane-2-Carboxylic
  • (文献来源)合成步骤主要原料 Wogonin 和 (2S,3S,4R,5R,6R)-6-[[[(2S,3S,4R,5R)-5-(2,4-Dioxopyrimidin-1-yl)-3,4-Dihydroxy-Oxolan-2-Yl]Methoxy-Hydroxy-Phosphoryl]Oxy-Hydroxy-Phosphoryl]Oxy-3,4,5-Trihydroxy-Oxane-2-Carboxylic
Wogonin 7-O-β-D-Ethylglucuronide置于sodium Hydroxide体系中,用 水 作为反应溶剂,化学反应生成 汉黄芩苷
参考文献:Flavonoids From Roots Of Scutellaria Intermedia
标题:Flavonoids From Roots Of Scutellaria Intermedia
摘要:
DOI:10.1007/s10600-018-2412-1

海关参考信息

专利信息


专利号:US-8377895-B2
优先权日:2008-07-10
标 题 :Cyclin-dependent protein kinases inhibitors of Scutellaria flavonoid organic amine derivatives, synthesis and use thereof
发明人:ZHANG SHIXUAN; BAO YONGMING; SUN YUMING; LI KANGJIAN; ZOU LIANG; MA JIGANG; SUN XIAODAN; SHANG HAIYAN; LI JING
权利人:ZHANG SHIXUAN; BAO YONGMING; SUN YUMING; LI KANGJIAN; ZOU LIANG; MA JIGANG; SUN XIAODAN; SHANG HAIYAN; LI JING
摘要:The present invention provides a series of cyclin-dependent protein kinases (Cdks) inhibitors, Scutellaria flavonoid organic amine derivatives, synthesis and use thereof. The preparation method is as follows: taking Baicalein (or Wogonin) from Scutellaria baicalensis as lead compound, mixting it with formaldehyde solution and organic amine compounds based on the molar ratio of 1:1-1.2:1-1.2, adding methanol of duplicate weight than baicalein and reacting at 50-70° C., filtering the sediment and washing and then drying so as to get the product with a content of not less than 97% (weight). Similar to Flavopiridol and P276-00, the activity of baicalein organic amine derivatives inhibiting Cdks has an increase of 50 times compared with that of Baicalin. It can selectively induce apoptosis of the proliferative phase cancer cells, which has scarcely any influence to the normal structure, and it belongs to anticancer drugs of cell cycle inhibitor kind. The product has a rich source of raw materials and has simple process, high purity, low cost, clear metabolic mechanism, high efficiency and low toxicity, which can be made into oral preparations or injections together with acid salts and is expected to become high efficient and low toxicity anti-cancer and AIDS drugs.

专利号:CN-113046333-A
优先权日:2019-12-26
标题:Flavonoid-8-hydroxylase and its application in the synthesis of 8-hydroxyflavonoids

专利号:US-2006165821-A1
优先权日:2002-12-27
标 题 :Composition comprising scutellaria baicalensis and their uses thereof
发明人:ZHANG YONG; YE FEI; LI FAN
权利人:ZHANG YONG; YE FEI; LI FAN
摘要:This invention described various formula composite of Scutellaria baicalensis for various diseases and conditions. The formula takes the advantage of our recent discovery of Scutellaria baicalensis can inhibit cyclooxygenase-2 (COX-2) activity and expression, resulting in decrease of prostaglandin synthesis. COX-2 is involved in many biological processes, such as inflammation, pain, carcinogenesis, etc. Combination of Scutellaria baicalensis with lycopene can be used for cancer prevention, especially smoking induced. Combination of Scutellaria baicalensis with glucosamine and chondroitin can be used for arthritis. Finally, this invention disclosed various method to prepare this formula and composition.

专利号:US-2010197619-A1
优先权日:2008-07-10
标 题 :Cyclin-dependent protein kinases inhibitors of scutellaria flavonoid organic amine derivatives, synthesis and use thereof
上海永恒生物科技有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
电话:02169734790👤
⚠️参考联系方式
邮件:zbg@forever-biotech.com
销售经理: 顾正兵经理
联系电话:02169734790
手机号码: 13701898007
传真号码: 02169734790
中国 上海 上海市青浦区 上海青浦区公园东路1155号科技创业中心5019室
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

上海上海市青浦区上海青浦区公园东路1155号科技创业中心5019室
⚠️ 未注册 · 未认证企业
注册入口 声明: 数据来源:本内容基于各搜索引擎等公开数据整理,仅作展示用。请自行辨别 📄若企业需抹除相关内容或, 请联系方我们,我们即刻栓除。
天津马克生物科技有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
电话:022-26358246👤
⚠️参考联系方式
邮件:phytomarker@gmail.com
销售经理: 颜世利经理
联系电话:022-26358246
手机号码: 13516124324
传真号码: 022-26358246
天津市河北区天泰路福嘉园20-4-601
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

天津市河北区天泰路福嘉园20-4-601
⚠️ 未注册 · 未认证企业
注册入口 声明: 数据来源:本内容基于各搜索引擎等公开数据整理,仅作展示用。请自行辨别 📄若企业需抹除相关内容或, 请联系方我们,我们即刻栓除。
第 1 / 1 页
现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

主要参考文献


1: Gong Z, Yang H, Gao L, Liu Y, Chu Q, Luo C, Kang L, Zhai H, Xu Q, Wu W, Li N, Li R. Mechanisms of wogonoside in the treatment of atherosclerosis based on network pharmacology, molecular docking, and experimental validation. BMC Complement Med Ther. 2025 Jan 27;25(1):28. doi: 10.1186/s12906-025-04760-x.
2: Li X, Zhao S, Xie J, Li M, Tong S, Ma J, Yang R, Zhao Q, Zhang J, Xu A. Targeting the NF-κB p65-MMP28 axis: Wogonoside as a novel therapeutic agent for attenuating podocyte injury in diabetic nephropathy. Phytomedicine. 2025 Jan 24;138:156406. doi: 10.1016/j.phymed.2025.156406. Epub ahead of print.
286:127559. doi: 10.1016/j.talanta.2025.127559. Epub ahead of print. 26(1):100. doi: 10.3390/ijms26010100.

合成参考文献


参考文献:10.1016/s0304-4165(99)00152-x
摘要:Gao Z, Huang K, Yang X, Xu H. Free radical scavenging and antioxidant activities of flavonoids extracted from the radix of Scutellaria baicalensis Georgi. Biochimica et Biophysica Acta (BBA) - General Subjects. 1999 Nov;1472(3):643–50. doi: 10.1016/s0304-4165(99)00152-x.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知